F357-0357 Screening compound: 3-(3-methylphenyl)-1-[4-({4-[3-(4-methylphenyl)-1,2,4-oxadiazol-5-yl]-1H-imidazol-1-yl}methyl)phenyl]urea

F357-0357 Screening compound: 3-(3-methylphenyl)-1-[4-({4-[3-(4-methylphenyl)-1,2,4-oxadiazol-5-yl]-1H-imidazol-1-yl}methyl)phenyl]urea
F357-0357 Screening compound: 3-(3-methylphenyl)-1-[4-({4-[3-(4-methylphenyl)-1,2,4-oxadiazol-5-yl]-1H-imidazol-1-yl}methyl)phenyl]urea alternative view

Chemical Structure Depiction of ChemDiv screening compound F357-0357
3-(3-methylphenyl)-1-[4-({4-[3-(4-methylphenyl)-1,2,4-oxadiazol-5-yl]-1H-imidazol-1-yl}methyl)phenyl]urea

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

F357-0357

Molecular Formula

C27H24N6O2 (C27 H24 N6 O2)

Compound Name

3-(3-methylphenyl)-1-[4-({4-[3-(4-methylphenyl)-1,2,4-oxadiazol-5-yl]-1H-imidazol-1-yl}methyl)phenyl]urea

IUPAC name

3-(3-methylphenyl)-1-[4-({4-[3-(4-methylphenyl)-124-oxadiazol-5-yl]-1H-imidazol-1-yl}methyl)phenyl]urea

SMILES

Cc(cc1)ccc1-c1noc(-c2cn(Cc(cc3)ccc3NC(Nc3cc(C)ccc3)=O)cn2)n1

InChI

InChI=1S/C27H24N6O2/c1-18-6-10-21(11-7-18)25-31-26(35-32-25)24-16-33(17-28-24)15-20-8-12-22(13-9-20)29-27(34)30-23-5-3-4-19(2)14-23/h3-14,16-17H,15H2,1-2H3,(H2,29,30,34)

InChI Key

GYECLRSYARDRGL-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27118668

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

464.53

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

8.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

6.292

Distribution Coefficient, logD

6.292

Water Solubility, LogSw

-5.31

Polar Surface Area

76.010

Acid Dissociation Constant (pKa)

13.81

Base Dissociation Constant (pKb)

2.46

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

11.10

F357-0357 in Drug Discovery

Included in Screening Libraries

CORONAVIRUS Library (20774 compounds)

Regenerative Medicine Focused Library (23016 compounds)

Protein Tyrosine Phosphatase Non-receptor Type (PTPN) Targeted Library (32556 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Antiviral
  • Infections
  • Immune system
  • Musculoskeletal
  • Digestive system
  • Hemic and lymphatic
  • Cardiovascular
  • Skin
  • wounds
  • Cancer
  • Nervous system
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Endocrine
Targets:
  • Phosphatases

References: we are preparing a list of scientific research reports with F357-0357 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound F357-0357?
Check Price and Availability of F357-0357, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of F357-0357 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for F357-0357
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for F357-0357
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of F357-0357 available by request